1. Current Status of Clinical Trials on Tau Immunotherapies

   • Changyi Ji
   • Einar M. Sigurdsson

   Leading Article 08 June 2021 Pages: 1135 - 1152

   

2. Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions

   • Eric Y Lin
   • Paul C Adamson
   • Jeffrey D. Klausner

   Review Article Open access 07 June 2021 Pages: 1153 - 1169

3. Neurokinin-1 Antagonists for Postoperative Nausea and Vomiting

   • Zhaosheng Jin
   • Neil Daksla
   • Tong J. Gan

   Review Article 09 June 2021 Pages: 1171 - 1179

   

4. Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents

   • Sho Hasegawa
   • Masato Yoneda
   • Atsushi Nakajima

   Review Article Open access 17 June 2021 Pages: 1181 - 1192

   

5. Remimazolam: A Review in Procedural Sedation

   • Arnold Lee
   • Matt Shirley

   Adis Drug Evaluation 01 July 2021 Pages: 1193 - 1201

   

6. Bupivacaine/Meloxicam Prolonged Release: A Review in Postoperative Pain

   • Hannah A. Blair

   Adis Drug Evaluation 06 July 2021 Pages: 1203 - 1211

7. Dostarlimab: First Approval

   • Anthony Markham

   AdisInsight Report 09 June 2021 Pages: 1213 - 1219

   

8. Fuzuloparib: First Approval

   • Arnold Lee

   AdisInsight Report Open access 12 June 2021 Pages: 1221 - 1226

   

9. Correction to: Fuzuloparib: First Approval

   • Arnold Lee

   Correction 10 July 2021 Pages: 1227 - 1227

10. Loncastuximab Tesirine: First Approval

    • Arnold Lee

    AdisInsight Report 18 June 2021 Pages: 1229 - 1233

    

11. Post-COVID-19 Syndrome: Leveraging the Patient Perspective and Technological Innovations to Enable the Delineation of Effective Treatments

    • Matthew T. Roe
    • Bray Patrick-Lake
    • Andrew C. von Eschenbach

    Letter to the Editor 16 June 2021 Pages: 1235 - 1237

    

12. Correction to: Entrectinib: A Review in NTRK+ Solid Tumours and ROS1+ NSCLC

    • James E. Frampton

    Correction Open access 28 May 2021 Pages: 1239 - 1239

13. Correction to: Lazertinib: First Approval

    • Sohita Dhillon

    Correction Open access 09 June 2021 Pages: 1241 - 1241